Featured
Last news
Pharmacy Benefit Managers: Driving Cost Savings and Innovation in Healthcare
Real value in working with Canada Drugs Direct as a partner pharmacy that is able to serve as a PBM
World’s largest Psychedelic Church to Close SF Site in Coming Weeks Pastor Cites Harassment from City Planning Department
Zide Door, the psychedelic church garnering national recognition for its devotion to the spiritual power of psilocybin mushrooms, will close its San Francisco location by the end of this year - the victim of a city planning department bent on expelling the institution, Pastor Dave Hodges said Tuesday.Church of Ambrosia, which opened Zide Door April 15, 2023, will continue to serve all 120,000 church members at its founding site in Oakland, he said. The Oakland church showcases an impressive mural and other significant psychedelic art.
Groundbreaking Collaboration: Vivos Therapeutics and Cellev8 Nutrition Join Forces to Address Sleep Apnea and Oxidative Stress
Cellev8 Nutrition Inc. (OTC Pink:CELV) and Vivos Therapeutics, Inc. today announced a strategic joint marketing venture aimed at providing comprehensive solutions for patients with obstructive sleep apnea (OSA) and associated oxidative stress. This collaboration combines Vivos Therapeutics' FDA-cleared oral medical devices for treating moderate to severe OSA in children and adults with Cellev8 Nutrition's proprietary gummy form of nutraceuticals featuring the powerful enzymatic antioxidant, SOD2, designed to mitigate oxidative stress in the body.
Hemogenyx Pharmaceuticals PLC Announces Admission of New Ordinary Shares and New ISIN
Admission of New Ordinary Shares and New ISIN
DEA Continues to Block MMJ Marijuana Drug Development for Neurological Disorder
MMJ Submits FDA Investigational New Drug Application for Cannabis-Derived Drug
Tallahassee Plastic Surgery Clinic Launches Nouvo Med Spa - Area's Newest Destination in Non-Invasive Aesthetic Care
Tallahassee Plastic Surgery Clinic has introduced Nouvo Med Spa, an advanced medical spa offering cutting-edge non-surgical aesthetic treatments under the guidance of the clinic's experienced plastic surgeons. Located at 2458 Mahan Drive, Suite 103, Nouvo Med Spa offers non-invasive cosmetic and aesthetic services in a modern, inviting setting as a complement to the services offered by Tallahassee Plastic Surgery Clinic.
Dolphin Entertainment Embarks on an Inspiring Journey to Adapt Clare Mulley's Award-Winning Debut Biography the Woman Who Saved the Children Into a Feature Film
Dolphin Entertainment (NASDAQ:DLPN) proudly announces its latest scripted content project with the acquisition of rights to The Woman Who Saved the Children, an acclaimed biography by award-winning author Clare Mulley. The book, which chronicles the extraordinary life of humanitarian trailblazer Eglantyne Jebb, will be brought to life as a feature film under Dolphin's production banner.
Dr. Amir Bajoghli and Team Publish New Case Study on Aquagenic Urticaria in BMJ Journals
Dr. Amir Bajoghli and his colleagues have recently published an insightful case study in BMJ Journals, titled "Aquagenic Urticaria in an Adolescent: Differential Diagnosis and Management." The study examines a rare case of aquagenic urticaria and underscores the importance of accurate diagnosis and effective management strategies for this unusual condition.
Noble Roman's Announces Additional Growth
Noble Roman's, Inc. (OTCQB:NROM), the Indianapolis based franchisor and licensor of Noble Roman's Pizza and Noble Roman's Craft Pizza & Pub, announced the continued rapid expansion of its non-traditional franchises, primarily in convenience stores and travel plazas. According to the company's current opening schedule, it will open approximately 19 new franchise locations in the fourth quarter of 2024, which includes three new units for Majors Management LLC. As the numbers indicate, the company maintains an extremely diversified sales and new unit pipeline in addition to the multi-unit Majors Management development agreement. With the additional new unit openings in the 4th quarter, the company expects a total of approximately 70 new unit openings in 2024. In addition, the company is building a significant backlog of new units to open in the first quarter of 2025, including several more Majors Management locations.
Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne
- This is Dermata's first allowed U.S. patent application for DMT310, using its Spongilla technology to topically treat acne -- Dermata recently completed enrollment in its DMT310 Phase 3 STAR-1 study for the treatment of acne and expects to announce topline results in March 2025 -- Over 30 million acne patients seek treatment in the U.S. each year, with topical products being first-line therapy -
Taiwan SAKURA Introduces Advanced Kitchen Solutions for Healthier Living
Invisible threats like kitchen fumes pose serious risks to your family's health, but now there's a solution. Taiwan SAKURA M6000 wall-mount chimney range hood is designed to tackle these challenges with cutting-edge technology, offering powerful smoke capture and efficient filtration to keep your kitchen fresh and your family safe. With its sleek design and advanced features, it redefines what a modern kitchen should be.
MIRA Pharmaceuticals Validates Ketamir-2's Safety Profile With No Adverse Findings, Paving the Way for IND Submission by Year-End
Strong Safety Profile Validated Across Studies, Setting the Stage for Clinical Trials in Neuropathic Pain
Ignite Biomedical Achieves Key Milestone in Precision Medicine with Successful Analytical Validation of TNF-alpha Inhibitor Treatment Response Predictor
Validation Results Pave the Way for Clinical Studies Focused on Transforming Patient Outcomes inInflammatory BowelDisease
Ensysce Biosciences Announces Commercial Supplier for Breakthrough Overdose Protection Drug Product
~ Supply Chain Now Fully Secure for PF614-MPAR ~
Quantum Biopharma Announces That the Safety Review Committee Recommends Commencing Dosing of Second Cohort in the Phase 1 Multiple Ascending Dose Clinical Trial for Lucid-21-302 (Lucid-MS)
Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, today announces through its subsidiary, HUGE Biopharma Australia Pty Ltd., that the safety review committee recommends commencing dosing of the second cohort in its trial entitled "A Phase 1, Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety and Pharmacokinetics of Lucid-21-302 in Healthy Adult Participants." The safety review committee made this recommendation after reviewing safety and pharmacokinetic data from participants in the first cohort.
VisiRose Introduces Revolutionary Therapy for Severe Eye Infections
Collaboration between Bascom Palmer Eye Institute and Provectus Biopharmaceuticals
MD+DI Names Babson Diagnostics, 2024 Medtech Company of the Year
MD+DI editors mark Babson Diagnostics as a notable true solution to deliver simplified blood testing through BetterWay.
Interactive Strength Inc. (Nasdaq:TRNR) Regains Full Compliance With Nasdaq Continued Listing Standards
Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that the Company received a letter from the Staff at Nasdaq Listings Qualifications stating that the Company has regained compliance with Listing Rule 5550(a)(2), which specifies rules regarding a minimum bid price of $1.00.
InterContinental Hotels Group PLC Announces Transaction in Own Shares - December 10
The Company announces that on 09 December 2024 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 3 May 2024 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 20 February 2024, as announced on 20 February 2024.
Brainy, 'normal guy': the suspect in US insurance CEO's slaying
The suspect in the high-profile killing of a health insurance CEO that has gripped the United States graduated from an Ivy League university, reportedly hails from a wealthy family, and wrote social media posts brimming with cerebral musings.
Connected, brainy, athletic: the suspect in US insurance CEO's slaying
The suspect in the high-profile killing of a health insurance CEO that has gripped the United States graduated from an Ivy League university, reportedly hails from a wealthy family, and wrote social media posts brimming with cerebral musings.
Suspect arrested after hunt for US insurance chief's killer
A 26-year-old man was arrested Monday over the targeted killing of a health insurance executive on the streets of New York, with police crediting a McDonald's employee in Pennsylvania who spotted a suspicious-looking customer.
French film director denies child actor abuse in landmark trial
A French filmmaker accused of sexually assaulting actor Adele Haenel when she was 12 denied the charges Monday as his trial opened in Paris, five years after her allegations fired France's #MeToo movement.
Syria rebel leader discusses 'transfer of power' after Assad's fall
Syria's Islamist rebel leader on Monday began discussions on transferring power, a day after rebels dramatically unseated president Bashar al-Assad following decades of brutal rule.
Man questioned in case of murdered health exec
A man was being questioned Monday in connection with last week's killing of a top health insurance executive on a New York street, US media reported, as a nationwide hunt for the suspect continued.
Man questioned in case of murdered health exec: US media
A man was being questioned Monday in connection with last week's killing of a top health insurance executive on a New York street, US media reported, as a nationwide hunt for the suspect continued.
Beaten 'unconscious': police violence sparks outrage in Georgia
When Georgian protester Irakli Pipia started praying with a feeble voice, the policeman beating him drew closer to grasp what he was saying.
China probes Nvidia for 'violating' anti-monopoly law
China on Monday launched an investigation into US chip giant Nvidia for allegedly violating its anti-monopoly laws, a top government agency said, as the two countries race for global chipmaking dominance.
Despair grips Afghan women healthcare students facing ban
For Saja, studying nursing at a healthcare institute in Kabul was her last lifeline to make something of herself after women were banned from universities in Afghanistan two years ago.
French director accused of abusing star Haenel goes on trial
A French filmmaker accused of sexually assaulting actor Adele Haenel when she was 12 was to go on trial in Paris on Monday, five years after her allegations fired France's #MeToo movement.
Evacuations underway as Philippine volcano erupts
A volcano erupted in the central Philippines on Monday, sending a huge ash column high into the sky as the government ordered the evacuation of surrounding villages.
Trauma and terror of Kenya's kidnapped protesters
The Kenyan parliament was ablaze, protesters running through the streets, police firing into the crowds. Among them was John, who believed the unrest could bring about meaningful political change.